Search Results

There are 29561 results for: content related to: Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities

  1. You have free access to this content
    The use of vemurafenib in Australian patients with unresectable or metastatic melanoma containing the V600 BRAF gene mutation

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue S3, April 2014, Pages: 1–15, Michael P Brown and Georgina V Long

    Article first published online : 8 APR 2014, DOI: 10.1111/ajco.12200

  2. Improved human bioavailability of vemurafenib, a practically insoluble drug, using an amorphous polymer-stabilized solid dispersion prepared by a solvent-controlled coprecipitation process

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 3, March 2013, Pages: 967–981, Navnit Shah, Raman M. Iyer, Hans-Juergen Mair, Duk Soon Choi, Hung Tian, Ralph Diodone, Karsten Fähnrich, Anni Pabst-Ravot, Kin Tang, Emmanuel Scheubel, Joseph F. Grippo, Sebastian A. Moreira, Zenaida Go, James Mouskountakis, Theresa Louie, Prabha N. Ibrahim, Harpreet Sandhu, Linda Rubia, Hitesh Chokshi, Dharmendra Singhal and Waseem Malick

    Article first published online : 29 DEC 2012, DOI: 10.1002/jps.23425

  3. You have free access to this content
    Society for Melanoma Research 2012 Congress

    Pigment Cell & Melanoma Research

    Volume 25, Issue 6, November 2012, Pages: 836–903,

    Article first published online : 19 OCT 2012, DOI: 10.1111/pcmr.12023

  4. Vemurafenib skin phototoxicity is indirectly linked to ultraviolet A minimal erythema dose decrease

    British Journal of Dermatology

    C. Brugière, A. Stefan, C. Morice, E. Cornet, A. Moreau, S. Allouche and L. Verneuil

    Article first published online : 9 NOV 2014, DOI: 10.1111/bjd.13300

  5. Vemurafenib-induced interface dermatitis manifesting as radiation-recall and a keratosis pilaris-like eruption

    Journal of Cutaneous Pathology

    Volume 41, Issue 6, June 2014, Pages: 539–543, Inbal Braunstein, Tara C. Gangadhar, Rosalie Elenitsas and Emily Y. Chu

    Article first published online : 11 MAR 2014, DOI: 10.1111/cup.12318

  6. You have free access to this content
    Society for Melanoma Research 2014 Congress

    Pigment Cell & Melanoma Research

    Volume 27, Issue 6, November 2014, Pages: 1169–1241,

    Article first published online : 23 OCT 2014, DOI: 10.1111/pcmr.12317

  7. You have free access to this content
    Society for Melanoma Research 2013 Congress

    Pigment Cell & Melanoma Research

    Volume 26, Issue 6, November 2013, Pages: 932–1019,

    Article first published online : 24 OCT 2013, DOI: 10.1111/pcmr.12166

  8. The effects of a high-fat meal on single-dose vemurafenib pharmacokinetics

    The Journal of Clinical Pharmacology

    Volume 54, Issue 4, April 2014, Pages: 368–374, Antoni Ribas, Weijiang Zhang, Ilsung Chang, Keisuke Shirai, Marc S. Ernstoff, Adil Daud, C. Lance Cowey, Gregory Daniels, Elizabeth Seja, Elizabeth O'Laco, John A. Glaspy, Bartosz Chmielowski, Todd Hill, Andrew K. Joe and Joseph F. Grippo

    Article first published online : 22 JAN 2014, DOI: 10.1002/jcph.255

  9. Progression of KRAS mutant pancreatic adenocarcinoma during vemurafenib treatment in a patient with metastatic melanoma

    Internal Medicine Journal

    Volume 44, Issue 6, June 2014, Pages: 597–600, A. Grey, A. Cooper, C. McNeil, S. O'Toole, J. Thompson and P. Grimison

    Article first published online : 19 JUN 2014, DOI: 10.1111/imj.12415

  10. Developing melanoma therapeutics: overview and update

    Wiley Interdisciplinary Reviews: Systems Biology and Medicine

    Volume 5, Issue 3, May/June 2013, Pages: 257–271, John B. Korman and David E. Fisher

    Article first published online : 13 FEB 2013, DOI: 10.1002/wsbm.1210

  11. You have free access to this content
    2011 International Melanoma Congress

    Pigment Cell & Melanoma Research

    Volume 24, Issue 5, October 2011, Pages: 990–1075,

    Article first published online : 10 OCT 2011, DOI: 10.1111/j.1755-148X.2011.00909.x

  12. 23. Deutscher Hautkrebskongress 2013 und ADO-Jahrestagung vom 26. bis 28. September 2013 in Essen

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 11, Issue 9, September 2013, Pages: 900–964,

    Article first published online : 19 AUG 2013, DOI: 10.1111/ddg.12189

  13. A case of vemurafenib-induced polyarhritis in a patient with melanoma: how to manage it?

    International Journal of Rheumatic Diseases

    Taner Babacan, Ibrahim Halil Türkbeyler, Ozan Balakan, Yavuz Pehlivan, Ali Suner and Bunyamin Kısacık

    Article first published online : 12 MAY 2014, DOI: 10.1111/1756-185X.12396

  14. Case of vemurafenib-induced Sweet's syndrome

    The Journal of Dermatology

    Volume 41, Issue 9, September 2014, Pages: 817–820, Jeffrey T. Yorio, Steven R. Mays, Ana M. Ciurea, Philip R. Cohen, Wei-Lien Wang, Wen-Jen Hwu, Nydia Gonzalez, Jessica L. Richard and Kevin B. Kim

    Article first published online : 12 MAR 2014, DOI: 10.1111/1346-8138.12430

  15. Histopathologic characteristics of therapy-associated cutaneous neoplasms with vemurafenib, a selective BRAF kinase inhibitor, used in the treatment of melanoma

    Journal of Cutaneous Pathology

    Volume 41, Issue 7, July 2014, Pages: 568–575, Kari E. Sufficool, Donna M. Hepper, Gerald P. Linette, Eva A. Hurst, Dongsi Lu, Anne C. Lind and Lynn A. Cornelius

    Article first published online : 29 APR 2014, DOI: 10.1111/cup.12346

  16. Acute renal failure associated with the new BRAF inhibitor vemurafenib: A case series of 8 patients

    Cancer

    Volume 120, Issue 14, 15 July 2014, Pages: 2158–2163, Vincent Launay-Vacher, Sarah Zimner-Rapuch, Nicolas Poulalhon, Thibault Fraisse, Valérie Garrigue, Morgane Gosselin, Sabine Amet, Nicolas Janus and Gilbert Deray

    Article first published online : 15 APR 2014, DOI: 10.1002/cncr.28709

  17. Bench to bedside: mechanistic principles of targeting the RAF kinase in melanoma

    International Journal of Dermatology

    Volume 53, Issue 12, December 2014, Pages: 1428–1433, Thanashan Rajakulendran and David N. Adam

    Article first published online : 14 OCT 2014, DOI: 10.1111/ijd.12724

  18. 22. Deutscher Hautkrebs-Kongress 2012 und ADO Jahrestagung vom 13. bis 15. September 2012 in Hannover

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 10, Issue 9, September 2012, Pages: 674–698,

    Article first published online : 24 AUG 2012, DOI: 10.1111/j.1610-0387.2012.08010.x

  19. You have free access to this content
    Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma

    IUBMB Life

    Volume 65, Issue 9, September 2013, Pages: 748–758, Ao-Xue Wang and Xiao-Yi Qi

    Article first published online : 29 JUL 2013, DOI: 10.1002/iub.1193

  20. You have free access to this content
    The Yin-Yang of RAF inhibitors

    Pigment Cell & Melanoma Research

    Volume 25, Issue 2, March 2012, Pages: 127–128, Ha Linh Vu and Andrew E. Aplin

    Article first published online : 19 JAN 2012, DOI: 10.1111/j.1755-148X.2011.00947.x